Pure Bioscience (PURE) Files 12.47M Common Shelf for Shareholders
Tweet
Share
E-mail
Pure Bioscience (Nasdaq: PURE) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 12,470,711 shares of Common Stock on behalf of Selling Shareholders.
Pure Bioscience will not receive proceeds from the sales.
Pure Bioscience will not receive proceeds from the sales.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- loanDepot receives NYSE non-compliance notice over stock price
- Gossamer Bio raises up to $250M in private placement for PAH drug
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
